Active — Not RecruitingNot Applicable

ABX Versus CHX in NSPT

Italy40 participantsStarted 2025-09-09

Plain-language summary

The study aims to compare the efficacy of a novel mouthwash based on microRepair ABX and an antibacterial complex with that of 0.12% chlorhexidine, both used as adjuncts to scaling and root planing.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with Stage I, II and III periodontal disease;
✓. Age between 30 and 70 years;
✓. ASA I or II patients;
✓. Light smokers (\<10 cigarettes per day);
✓. Patients not already using the study products

Exclusion criteria

✕. Patients with Stage IV periodontal disease;
✕. HbA1c \> 7% 3 ASA \> III 4 Severe smokers 5 Patients already using the study products

What they're measuring

Probing depth

Timeframe: From enrollment to the end of treatment at 12 weeks and at 24 weeks

full mouth bleeding score

Timeframe: from baseline to 12 and 24 weeks after full mouth disinfection

Trial details

NCT IDNCT07520968

SponsorUniversity of Roma La Sapienza

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11-01

View on ClinicalTrials.gov More Periodontal Disease trials